Actinium Pharmaceuticals (ATNM) Assets (2010 - 2026)
Actinium Pharmaceuticals (ATNM) posted quarterly Assets of $45.4 million for Q1 2026, down 33.81% year-over-year from $68.6 million in Q1 2025, and down 12.24% quarter-over-quarter from $51.8 million in Q4 2025.
Actinium Pharmaceuticals (ATNM) Assets (2010 - 2026) Analysis & Trends
Actinium Pharmaceuticals (ATNM) has reported Assets for 17 consecutive years, with $45.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets fell 33.81% year-over-year to $45.4 million; the TTM figure through Mar 2026 stood at $45.4 million (down 33.81% YoY), while the FY2025 annual figure was $51.8 million, down 32.67% from the prior year.
- Assets slipped to $45.4 million in Q1 2026 per ATNM's latest filing, from $51.8 million in the prior quarter.
- Across five years, Assets topped out at $121.8 million in Q2 2022 and bottomed at $45.4 million in Q1 2026.
- Historically, Assets has averaged $83.6 million across 5 years, with a median of $82.1 million in 2024.
- Annual changes were most pronounced in 2022 — Assets soared 44.22% — and 2026, when it slumped 33.81%.
- Actinium Pharmaceuticals' Assets stood at $114.2 million in 2022, then dropped by 28.68% to $81.4 million in 2023, then declined by 5.58% to $76.9 million in 2024, then plunged by 32.67% to $51.8 million in 2025, then dropped by 12.24% to $45.4 million in 2026.
- Business Quant data shows ATNM's Assets at $45.4 million in Q1 2026, $51.8 million in Q4 2025, and $56.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | Actinium Pharmaceuticals | 35.17 Mn | 35.17 Mn | - | 40.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.16 Mn |
| Mar 31, 2026 | 45.44 Mn |
| Dec 31, 2025 | 51.78 Mn |
| Sep 30, 2025 | 56.15 Mn |
| Jun 30, 2025 | 63.02 Mn |
| Mar 31, 2025 | 68.65 Mn |
| Dec 31, 2024 | 76.90 Mn |
| Sep 30, 2024 | 82.11 Mn |
| Jun 30, 2024 | 89.86 Mn |
| Mar 31, 2024 | 88.35 Mn |
| Dec 31, 2023 | 81.45 Mn |
| Sep 30, 2023 | 88.94 Mn |
| Jun 30, 2023 | 99.05 Mn |
| Mar 31, 2023 | 102.03 Mn |
| Dec 31, 2022 | 114.19 Mn |
| Sep 30, 2022 | 116.82 Mn |
| Jun 30, 2022 | 121.80 Mn |
| Mar 31, 2022 | 74.56 Mn |
| Dec 31, 2021 | 80.39 Mn |
| Sep 30, 2021 | 84.48 Mn |